Paul Reilly

1 ta ish

Boehringer Ingelheim (United States)

1. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

   Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf +17

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.292663